Silybin AB (mixture) is a flavonolignan mixture used primarily as an adjunctive therapy for the treatment of toxic liver damage, including conditions such as chronic hepatitis and cirrhosis. This compound… Read more
Silybin AB (mixture) is a flavonolignan mixture used primarily as an adjunctive therapy for the treatment of toxic liver damage, including conditions such as chronic hepatitis and cirrhosis. This compound acts by stabilizing hepatocyte cell membranes and inhibiting free radical formation, effectively protecting liver tissue from oxidative stress. To support the rigorous demands of pharmaceutical research and development, this category features a comprehensive selection of high-quality reference standards, including pharmacopeial and non-pharmacopeial impurities, metabolites, and stable isotope-labelled compounds. These materials are essential for pharmaceutical laboratories performing impurity profiling, method development, and validation to ensure the quality, safety, and regulatory compliance of Silybin AB (mixture) formulations. Using these precise analytical tools enables researchers to accurately identify and quantify related substances, supporting precise quality control throughout the product lifecycle.